I found this week's BMJ very instructive with it's number
of articles on tamiful. This once again shows the tangled
web of pharmaceutical company involvement in publications.
This makes a perfect case for evidence based practice and
why need regular critical appraisal of published studies.
For me two other important issues are:
1. a case for publicly accessible trial data for all
peer-review publication and
2. independent statistical analysis of study data
Munier
|